Ansell Limited Makes an Announcement for FY 2019 Half-Year Results: What Market Players Need to Know


Ansell Limited (ASX: ANN) had come forward and made an announcement about the FY2019 half-yearly results for the period ending December 31, 2018 with the help of the press release. As per the press release dated February 18, 2019, the company had posted sales amounting to US$725.3 million which reflects the rise of 0.4% with regards to the continuing operations on the YoY basis. The release also contained the viewpoints of Mr. Glenn Barnes who is the Chairman of Ansell Limited. Mr. Glenn Barnes had stated that the company had continued to make deployments towards the strategic growth initiatives to position Ansell Limited for sustained future growth. He added that there was an environment in which the growth in the profit was temporarily constrained because of the higher raw material costs. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Mr. Barnes added that there are expectations that Ansell Limited might exceed original savings targets. According to the release issued by the company, the company’s fiscal year 2019 commenced amid some challenging external headwinds which also includes the increasing costs of the raw materials, risks with respect to US import tariffs as well as some emerging areas of demand uncertainty in EMEA automotive sector and in select emerging markets which includes Russia and Brazil. With regards to Healthcare GBU,  the company stated that the sales witnessed a rise of 4.2% in constant currency which also includes contribution of Digitcare acquisition in the H1 FY 2019 and the organic revenue growth stood at 3.8% which excludes the acquisition benefits that happens to the arise from growth of 15.4% with respect to new product sales as well as growth of 2.8% with regards to sales to the emerging markets.

As per the press release issued by Ansell Limited, with regards to Industrial GBU, the sales encountered a rise of 0.2% in constant currency whilst organic revenue growth witnessed a rise of 0.3%. The release also contained information about the dividends. The company has declared an interim dividend amounting to US20.75¢ per share. The company added that the record date would be February 25, 2019 as well as the payment date would be March 14, 2019.

We would now have a look at how Ansell Limited’s stock is performing today and how it has performed in the past few months. Today (i.e. February 18, 2018, AEST 4:00 PM), at the time of writing, the stock of Ansell Limited is trading in green as the stock price is witnessing a rise of A$0.990 per share or 4.088% and is presently trading at A$25.090 per share. The market capitalization of Ansell Limited stood at $3.21 billion. The annual dividend yield of Ansell Limited stood at 2.48%. Talking about the past performance, the company’s stock had posted the return of -13.81% in the time span of previous 6 months, while in the period of previous three months, the stock of Ansell Limited had delivered the return of 5.03%. However, in the time frame of the previous one month, the stock’s return stood at 6.65%.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report